About this grant
<div class="" data-turn-id-container="request-6a5779d7-3974-83ea-af75-bab9567399bc-15" data-is-intersecting="true">
<section class="text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [&:has([data-writing-block])>*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" data-turn-id="request-6a5779d7-3974-83ea-af75-bab9567399bc-15" data-turn-id-container="request-6a5779d7-3974-83ea-af75-bab9567399bc-15" data-testid="conversation-turn-220" data-turn="assistant">
<div class="text-base my-auto mx-auto [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)">
<div class="[--thread-content-max-width:40rem] @w-lg/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn" data-conversation-screenshot-content="">
<div class="flex max-w-full flex-col gap-4 grow">
<div class="min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&]:mt-1" dir="auto" data-message-author-role="assistant" data-message-id="6bf6d06a-11d7-4f28-ba61-d9ba8fbcb3d3" data-message-model-slug="gpt-5-6-thinking">
<div class="flex w-full flex-col gap-1 empty:hidden">
<p data-start="105" data-end="303">Three major federal funding windows are available in 2026 for U.S. startups and small businesses developing technologies in health, deep tech, national security and other research-intensive sectors.</p>
<p data-start="305" data-end="638">The opportunities come from the <strong data-start="337" data-end="376">National Institutes of Health (NIH)</strong>, the <strong data-start="382" data-end="424">U.S. National Science Foundation (NSF)</strong> and the <strong data-start="433" data-end="543">U.S. Department of Defense Small Business Innovation Research/Small Business Technology Transfer ecosystem</strong>, including opportunities administered through components such as the Defense Logistics Agency.</p>
<p data-start="640" data-end="930">Together, these programmes provide non-dilutive federal research and development funding that can help small companies establish technical feasibility, develop prototypes, advance research toward commercialization and build partnerships with universities or nonprofit research institutions.</p>
<p data-start="932" data-end="1114">Founders should pay particular attention to the upcoming 2026 deadlines because each programme operates under different submission rules, eligibility requirements and funding phases.</p>
<h2 data-section-id="6ojhic" data-start="1116" data-end="1187">1. NIH Small Business Technology Transfer Grant: Parent STTR R41/R42</h2>
<p data-start="1189" data-end="1452">The <strong data-start="1193" data-end="1289">NIH Small Business Technology Transfer Grant, Parent STTR [R41/R42], Clinical Trial Optional</strong>, is designed to support U.S. small businesses conducting biomedical or life-sciences research and development in partnership with nonprofit research institutions.</p>
<p data-start="1454" data-end="1598">The funding opportunity is listed as <strong data-start="1491" data-end="1504">PA-27-102</strong> and is part of the federal STTR programme, also commonly associated with America’s Seed Fund.</p>
<h3 data-section-id="164bxz4" data-start="1600" data-end="1632">About the NIH STTR Programme</h3>
<p data-start="1634" data-end="1845">NIH uses the SBIR and STTR programmes to help U.S.-owned and operated small businesses develop technologies and products that support its mission to improve health, extend life and reduce illness and disability.</p>
<p data-start="1847" data-end="2003">STTR differs from SBIR because projects funded through STTR must include a formal collaboration with a nonprofit research institution, such as a university.</p>
<p data-start="2005" data-end="2203">The Principal Investigator may be employed by either the small business or the collaborating nonprofit research institution. However, the funding award itself is made to the eligible small business.</p>
<p data-start="2205" data-end="2335">Businesses whose projects do not require this type of institutional collaboration may instead consider the NIH SBIR funding route.</p>
<h3 data-section-id="fhk3i" data-start="2337" data-end="2375">What the NIH STTR Funding Supports</h3>
<p data-start="2377" data-end="2498">The programme supports research and development required to move an innovative idea toward a commercially viable product.</p>
<p data-start="2500" data-end="2560">Eligible applications may fall under several funding stages:</p>
<ul data-start="2562" data-end="2951">
<li data-section-id="12qt57b" data-start="2562" data-end="2621"><strong data-start="2564" data-end="2576">Phase I:</strong> Establishes technical merit and feasibility.</li>
<li data-section-id="1pkgu21" data-start="2622" data-end="2698"><strong data-start="2624" data-end="2637">Phase II:</strong> Continues research and development toward commercialization.</li>
<li data-section-id="1dyxweu" data-start="2699" data-end="2866"><strong data-start="2701" data-end="2724">Direct to Phase II:</strong> Available through NIH for businesses that have already demonstrated feasibility without previously receiving a Phase I award for the project.</li>
<li data-section-id="oyhisp" data-start="2867" data-end="2951"><strong data-start="2869" data-end="2884">Fast-Track:</strong> Allows Phase I and Phase II to be submitted and reviewed together.</li>
</ul>
<p data-start="2953" data-end="3059">After Phase II, NIH generally expects companies to continue commercialization using non-SBIR/STTR funding.</p>
<h3 data-section-id="15nm6dx" data-start="3061" data-end="3079">Research Scope</h3>
<p data-start="3081" data-end="3169">Proposals should contribute to the missions of participating NIH, CDC or FDA components.</p>
<p data-start="3171" data-end="3355">Relevant projects may span biomedical technologies, health technologies, diagnostics, life sciences, medical research and other areas aligned with participating institutes and centres.</p>
<p data-start="3357" data-end="3513">Applicants are encouraged to contact the appropriate NIH Institute, Center or Office before submission to determine whether their project is a suitable fit.</p>
<p data-start="3515" data-end="3717">Clinical trials may be included under the Parent STTR opportunity, but some participating NIH Institutes and Centers do not accept clinical-trial applications through this specific funding announcement.</p>
<p data-start="3719" data-end="3817">Applicants proposing clinical research should therefore carefully review component-specific rules.</p>
<h3 data-section-id="owwgco" data-start="3819" data-end="3847">NIH Application Timeline</h3>
<p data-start="3849" data-end="3937">The funding opportunity was released on <strong data-start="3889" data-end="3904">28 May 2026</strong> and opened on <strong data-start="3919" data-end="3936">5 August 2026</strong>.</p>
<p data-start="3939" data-end="3984">The solicitation lists standard due dates of:</p>
<ul data-start="3986" data-end="4036">
<li data-section-id="w9q6r8" data-start="3986" data-end="4004">5 September 2026</li>
<li data-section-id="8l1t40" data-start="4005" data-end="4021">5 January 2027</li>
<li data-section-id="13t3s7w" data-start="4022" data-end="4036">5 April 2027</li>
</ul>
<p data-start="4038" data-end="4232">The provided funding summary notes that the <strong data-start="4082" data-end="4152">September 2026 submission deadline is effectively 8 September 2026</strong>, because 5 September falls on a Saturday and the following Monday is Labor Day.</p>
<p data-start="4234" data-end="4341">Applicants should verify the operative deadline through the official agency solicitation before submission.</p>
<h3 class="markdown prose dark:prose-invert wrap-break-word w-full light markdown-new-styling" style="text-align: center;"><a href="https://www.sbir.gov/topics/12564" target="_blank" rel="noopener"><b>APPLY HERE</b></a></h3>
<hr data-start="4387" data-end="4390" />
<h2 style="text-align: left;" data-section-id="x34fph" data-start="4392" data-end="4455">2. NSF SBIR/STTR Phase I, Phase II and Fast-Track Programmes</h2>
<p style="text-align: left;" data-start="4457" data-end="4733">The second opportunity is the <strong data-start="4487" data-end="4615">NSF 26-510 Small Business Innovation Research / Small Business Technology Transfer Phase I, Phase II and Fast-Track Programs</strong>, administered through the U.S. National Science Foundation’s Directorate for Technology, Innovation and Partnerships.</p>
<p style="text-align: left;" data-start="4735" data-end="4866">The programme supports startups and small businesses developing high-risk technologies with strong potential for commercial impact.</p>
<h3 style="text-align: left;" data-section-id="1w91fjj" data-start="4868" data-end="4899">What NSF SBIR/STTR Supports</h3>
<p style="text-align: left;" data-start="4901" data-end="5043">NSF describes the programme as a mechanism for transforming scientific discoveries and technological breakthroughs into products and services.</p>
<p style="text-align: left;" data-start="5045" data-end="5131">Funding can support technologies across a broad range of areas, potentially including:</p>
<ul style="text-align: left;" data-start="5133" data-end="5360">
<li data-section-id="1u78spn" data-start="5133" data-end="5158">Artificial intelligence</li>
<li data-section-id="g0eet1" data-start="5159" data-end="5169">Robotics</li>
<li data-section-id="1yui7f4" data-start="5170" data-end="5186">Semiconductors</li>
<li data-section-id="6zwyh6" data-start="5187" data-end="5202">Biotechnology</li>
<li data-section-id="1spx560" data-start="5203" data-end="5220">Medical devices</li>
<li data-section-id="xvzmgm" data-start="5221" data-end="5245">Advanced manufacturing</li>
<li data-section-id="13b91sf" data-start="5246" data-end="5268">Quantum technologies</li>
<li data-section-id="uum27" data-start="5269" data-end="5283">Clean energy</li>
<li data-section-id="1gcrobc" data-start="5284" data-end="5303">Data technologies</li>
<li data-section-id="f5o048" data-start="5304" data-end="5315">Computing</li>
<li data-section-id="hpbhxr" data-start="5316" data-end="5360">Other emerging and deep-technology sectors</li>
</ul>
<p style="text-align: left;" data-start="5362" data-end="5562">NSF does not generally procure specific products through this programme. Instead, it invests in the research and development needed to turn promising technologies into commercially viable innovations.</p>
<p style="text-align: left;" data-start="5564" data-end="5681">NSF takes no equity in funded businesses, and awardees retain ownership of their companies and intellectual property.</p>
<h3 style="text-align: left;" data-section-id="1xqdsjm" data-start="5683" data-end="5706">NSF Phase I Funding</h3>
<p style="text-align: left;" data-start="5708" data-end="5778">Phase I supports technical research and development at an early stage.</p>
<p style="text-align: left;" data-start="5780" data-end="5809">Businesses may request up to:</p>
<p style="text-align: left;" data-start="5811" data-end="5823"><strong data-start="5811" data-end="5823">$305,000</strong></p>
<p style="text-align: left;" data-start="5825" data-end="5885">Projects generally run for approximately <strong data-start="5866" data-end="5884">6 to 18 months</strong>.</p>
<p style="text-align: left;" data-start="5887" data-end="6037">Phase I is designed to reduce technical risk and establish whether a technology has sufficient merit and feasibility to justify continued development.</p>
<h3 style="text-align: left;" data-section-id="1xrey3" data-start="6039" data-end="6063">NSF Phase II Funding</h3>
<p style="text-align: left;" data-start="6065" data-end="6156">Phase II supports companies that have successfully completed an eligible NSF Phase I award.</p>
<p style="text-align: left;" data-start="6158" data-end="6176">Funding may reach:</p>
<p style="text-align: left;" data-start="6178" data-end="6192"><strong data-start="6178" data-end="6192">$1,250,000</strong></p>
<p style="text-align: left;" data-start="6194" data-end="6325">Phase II projects typically run for approximately <strong data-start="6244" data-end="6257">24 months</strong> and focus on advancing technical development and commercialization.</p>
<p style="text-align: left;" data-start="6327" data-end="6392">Only eligible NSF Phase I awardees may submit Phase II proposals.</p>
<h3 style="text-align: left;" data-section-id="apkkhy" data-start="6394" data-end="6420">NSF Fast-Track Funding</h3>
<p style="text-align: left;" data-start="6422" data-end="6489">The Fast-Track programme combines Phase I and Phase II development.</p>
<p style="text-align: left;" data-start="6491" data-end="6523">Funding may reach approximately:</p>
<p style="text-align: left;" data-start="6525" data-end="6539"><strong data-start="6525" data-end="6539">$1,555,000</strong></p>
<p style="text-align: left;" data-start="6541" data-end="6663">The Phase I portion may include up to $400,000, followed by up to approximately $1.155 million for the Phase II component.</p>
<h3 style="text-align: left;" data-section-id="r7bprg" data-start="6665" data-end="6700">Additional NSF Funding Pathways</h3>
<p style="text-align: left;" data-start="6702" data-end="6753">Existing Phase II awardees may also have access to:</p>
<ul style="text-align: left;" data-start="6755" data-end="6882">
<li data-section-id="t32tuz" data-start="6755" data-end="6778">Phase IIB supplements</li>
<li data-section-id="rlb1b4" data-start="6779" data-end="6843">Technology Enhancement for Commercial Partnerships supplements</li>
<li data-section-id="d4rgez" data-start="6844" data-end="6882">Strategic Breakthrough opportunities</li>
</ul>
<p style="text-align: left;" data-start="6884" data-end="7099">Strategic Breakthrough proposals may, following invitation or consultation with the relevant NSF Programme Officer, request substantially larger amounts for exceptional technologies approaching commercial readiness.</p>
<h3 style="text-align: left;" data-section-id="itjave" data-start="7101" data-end="7130">Project Pitch Requirement</h3>
<p style="text-align: left;" data-start="7132" data-end="7201">A major requirement applies to new Phase I and Fast-Track applicants.</p>
<p style="text-align: left;" data-start="7203" data-end="7325">Before submitting a full proposal, companies must submit an official <strong data-start="7272" data-end="7289">Project Pitch</strong> and receive an invitation from NSF.</p>
<p style="text-align: left;" data-start="7327" data-end="7426">For Phase I, the invitation generally remains valid for the next two eligible submission deadlines.</p>
<p style="text-align: left;" data-start="7428" data-end="7527">For Fast-Track, the full proposal must be submitted within four months of receiving the invitation.</p>
<p style="text-align: left;" data-start="7529" data-end="7596">NSF limits the number of Project Pitches that a company can submit.</p>
<h3 style="text-align: left;" data-section-id="f2vb74" data-start="7598" data-end="7617">NSF Eligibility</h3>
<p style="text-align: left;" data-start="7619" data-end="7675">Applicants must qualify as U.S. small business concerns.</p>
<p style="text-align: left;" data-start="7677" data-end="7776">The programme generally applies to firms with no more than <strong data-start="7736" data-end="7775">500 employees, including affiliates</strong>.</p>
<p style="text-align: left;" data-start="7778" data-end="7857">For STTR proposals, the business must also partner with a research institution.</p>
<p style="text-align: left;" data-start="7859" data-end="7995">The Principal Investigator must be primarily employed by the small business, generally meaning at least 51% employment with the company.</p>
<p style="text-align: left;" data-start="7997" data-end="8141">The PI must also have the legal right to work for the company in the United States. NSF does not impose a specific degree requirement on the PI.</p>
<h3 style="text-align: left;" data-section-id="zact5g" data-start="8143" data-end="8166">NSF Review Criteria</h3>
<p style="text-align: left;" data-start="8168" data-end="8226">Proposals are evaluated according to three major criteria:</p>
<ul style="text-align: left;" data-start="8228" data-end="8301">
<li data-section-id="10gxw2b" data-start="8228" data-end="8252"><strong data-start="8230" data-end="8252">Intellectual Merit</strong></li>
<li data-section-id="jjcc7o" data-start="8253" data-end="8274"><strong data-start="8255" data-end="8274">Broader Impacts</strong></li>
<li data-section-id="1u1tkro" data-start="8275" data-end="8301"><strong data-start="8277" data-end="8301">Commercial Potential</strong></li>
</ul>
<p style="text-align: left;" data-start="8303" data-end="8466">Strong proposals should therefore demonstrate not only interesting science or engineering, but also a realistic pathway from research to meaningful commercial use.</p>
<h3 style="text-align: left;" data-section-id="1mx2lkn" data-start="8468" data-end="8484">NSF Deadline</h3>
<p style="text-align: left;" data-start="8486" data-end="8527">The next major full-proposal deadline is:</p>
<p style="text-align: left;" data-start="8529" data-end="8605"><strong data-start="8529" data-end="8605">4 November 2026 at 5:00 p.m. in the submitting organisation’s local time</strong></p>
<p style="text-align: left;" data-start="8607" data-end="8666">Additional scheduled deadlines include March and July 2027.</p>
</div>
<h3 style="text-align: center;" data-start="8607" data-end="8666"><a href="https://www.nsf.gov/funding/opportunities/small-business-innovation-research-small-business-technology/nsf26-510/solicitation" target="_blank" rel="noopener">APPLY HERE</a></h3>
<div class="flex w-full flex-col gap-1 empty:hidden">
<hr data-start="8712" data-end="8715" />
<h2 style="text-align: left;" data-section-id="1qvgsno" data-start="8717" data-end="8773">3. Department of Defense SBIR/STTR 2026 Release Cycle</h2>
<p style="text-align: left;" data-start="8775" data-end="8859">The third opportunity comes through the U.S. Department of Defense SBIR/STTR system.</p>
<p style="text-align: left;" data-start="8861" data-end="8974">Participating defense components may release research topics addressing technological needs across areas such as:</p>
<ul style="text-align: left;" data-start="8976" data-end="9175">
<li data-section-id="2lzfxc" data-start="8976" data-end="8995">National security</li>
<li data-section-id="1o9snwy" data-start="8996" data-end="9006">Autonomy</li>
<li data-section-id="yshk98" data-start="9007" data-end="9027">Space technologies</li>
<li data-section-id="1b3zhwx" data-start="9028" data-end="9043">Cybersecurity</li>
<li data-section-id="ex10by" data-start="9044" data-end="9064">Advanced materials</li>
<li data-section-id="fjvzyz" data-start="9065" data-end="9092">Supply-chain technologies</li>
<li data-section-id="1hwkct7" data-start="9093" data-end="9104">Logistics</li>
<li data-section-id="ctpr48" data-start="9105" data-end="9120">Manufacturing</li>
<li data-section-id="1pu9c90" data-start="9121" data-end="9138">Defense systems</li>
<li data-section-id="6qhcwy" data-start="9139" data-end="9175">Other mission-related technologies</li>
</ul>
<p style="text-align: left;" data-start="9177" data-end="9288">The Defense Logistics Agency is one participating organisation within the broader defense innovation ecosystem.</p>
<h3 style="text-align: left;" data-section-id="5wry8q" data-start="9290" data-end="9328">About Defense SBIR/STTR Programmes</h3>
<p style="text-align: left;" data-start="9330" data-end="9528">The SBIR programme supports research and development conducted by qualifying small businesses, while STTR supports cooperative R&D involving small companies and nonprofit U.S. research institutions.</p>
<p style="text-align: left;" data-start="9530" data-end="9575">The programmes generally follow three phases:</p>
<ul style="text-align: left;" data-start="9577" data-end="9811">
<li data-section-id="1lvd9cq" data-start="9577" data-end="9626"><strong data-start="9579" data-end="9591">Phase I:</strong> Demonstrate technical feasibility.</li>
<li data-section-id="1srfxcd" data-start="9627" data-end="9706"><strong data-start="9629" data-end="9642">Phase II:</strong> Develop prototypes, processes or products for proof-of-concept.</li>
<li data-section-id="1rvbjt4" data-start="9707" data-end="9811"><strong data-start="9709" data-end="9723">Phase III:</strong> Commercial application of the technology using funding outside the SBIR/STTR set-aside.</li>
</ul>
<p style="text-align: left;" data-start="9813" data-end="9940">The broader objective is to stimulate innovation, advance commercialization and develop technologies relevant to defense needs.</p>
<h3 style="text-align: left;" data-section-id="i5oi8c" data-start="9942" data-end="9967">2026 Release Schedule</h3>
<p style="text-align: left;" data-start="9969" data-end="10043">The provided 2026 schedule includes multiple monthly-style release cycles.</p>
<p style="text-align: left;" data-start="10045" data-end="10063">For <strong data-start="10049" data-end="10062">Release 5</strong>:</p>
<ul style="text-align: left;" data-start="10065" data-end="10228">
<li data-section-id="sozs3n" data-start="10065" data-end="10093">Pre-release: 5 August 2026</li>
<li data-section-id="4yev2u" data-start="10094" data-end="10117">Opens: 26 August 2026</li>
<li data-section-id="16vi20v" data-start="10118" data-end="10149">Closes: <strong data-start="10128" data-end="10149">23 September 2026</strong></li>
<li data-section-id="wl3qhv" data-start="10150" data-end="10195">Evaluation period through: 22 December 2026</li>
<li data-section-id="53dik" data-start="10196" data-end="10228">Expected awards: 22 March 2027</li>
</ul>
<p style="text-align: left;" data-start="10230" data-end="10248">For <strong data-start="10234" data-end="10247">Release 6</strong>:</p>
<ul style="text-align: left;" data-start="10250" data-end="10334">
<li data-section-id="14v67re" data-start="10250" data-end="10281">Pre-release: 2 September 2026</li>
<li data-section-id="18xxym5" data-start="10282" data-end="10308">Opens: 23 September 2026</li>
<li data-section-id="172is9c" data-start="10309" data-end="10334">Closes: 21 October 2026</li>
</ul>
<p style="text-align: left;" data-start="10336" data-end="10364">Dates are subject to change.</p>
<p style="text-align: left;" data-start="10366" data-end="10559">Companies should monitor the Defense SBIR/STTR Innovation Portal for individual topics because technical requirements, participating components and eligibility details can vary by solicitation.</p>
<h3 style="text-align: left;" data-section-id="18qa1o0" data-start="10561" data-end="10588">Training and Compliance</h3>
<p style="text-align: left;" data-start="10590" data-end="10733">Companies participating in certain Defense Logistics Agency innovation programmes should also be aware of compliance and training requirements.</p>
<p style="text-align: left;" data-start="10735" data-end="10753">These may include:</p>
<ul style="text-align: left;" data-start="10755" data-end="10959">
<li data-section-id="1m34ddp" data-start="10755" data-end="10808">Cybersecurity Maturity Model Certification training</li>
<li data-section-id="1xhbncs" data-start="10809" data-end="10855">Controlled Unclassified Information training</li>
<li data-section-id="1dqusi8" data-start="10856" data-end="10907">Enhanced Joint Certification Program requirements</li>
<li data-section-id="qufae8" data-start="10908" data-end="10959">Foreign Ownership, Control and Influence training</li>
</ul>
<p style="text-align: left;" data-start="10961" data-end="11062">Applicants should review the requirements attached to the specific topic before preparing a proposal.</p>
</div>
<h3 style="text-align: center;" data-start="10961" data-end="11062"><a href="https://www.dla.mil/Small-Business/Vendor-Opportunities/Small-Business-Innovation-Programs/smdsort109475/program/" target="_blank" rel="noopener"><strong>APPLY HERE</strong></a></h3>
<div class="flex w-full flex-col gap-1 empty:hidden">
<hr data-start="11108" data-end="11111" />
<h2 style="text-align: left;" data-section-id="bethav" data-start="11113" data-end="11141">Key Deadlines to Remember</h2>
<p style="text-align: left;" data-start="11143" data-end="11219">For founders considering these three opportunities, the immediate dates are:</p>
<ul style="text-align: left;" data-start="11221" data-end="11458">
<li data-section-id="1dmdos2" data-start="11221" data-end="11336"><strong data-start="11223" data-end="11236">NIH STTR:</strong> September 2026 cycle; the provided summary identifies <strong data-start="11291" data-end="11311">8 September 2026</strong> as the adjusted deadline</li>
<li data-section-id="smsdso" data-start="11337" data-end="11393"><strong data-start="11339" data-end="11371">Defense SBIR/STTR Release 5:</strong> <strong data-start="11372" data-end="11393">23 September 2026</strong></li>
<li data-section-id="a0z86i" data-start="11394" data-end="11458"><strong data-start="11396" data-end="11414">NSF SBIR/STTR:</strong> <strong data-start="11415" data-end="11458">4 November 2026 at 5:00 p.m. local time</strong></li>
</ul>
<p style="text-align: left;" data-start="11460" data-end="11595">Because some programmes require preliminary steps, founders should not treat the full-proposal deadline as the date to begin preparing.</p>
<p style="text-align: left;" data-start="11597" data-end="11728">NSF Phase I and Fast-Track applicants, for example, must obtain a Project Pitch invitation before submitting the complete proposal.</p>
<h2 style="text-align: left;" data-section-id="8dtpi" data-start="11730" data-end="11743">Conclusion</h2>
<p style="text-align: left;" data-start="11745" data-end="11928">The NIH, NSF and Department of Defense SBIR/STTR programmes provide three substantial pathways for U.S. small businesses seeking non-dilutive research and development funding in 2026.</p>
<p style="text-align: left;" data-start="11930" data-end="12368">NIH may be particularly relevant to biomedical and health-focused companies collaborating with research institutions. NSF offers broad support for high-risk deep technologies with commercial potential, including funding of up to $305,000 for Phase I and $1.25 million for Phase II. Defense SBIR/STTR opportunities provide recurring topic-based windows for companies developing technologies relevant to national security and defense needs.</p>
<p style="text-align: left;" data-start="12370" data-end="12651">Founders should identify the programme that best matches their technology, confirm their eligibility and begin preparing well before the deadline. Federal innovation funding can be generous, but it rewards preparation; bureaucracy rarely becomes more charming when met at 4:57 p.m.</p>
</div>
<h4 data-start="12370" data-end="12651">To discover more grant opportunities, <a href="https://opportunitiesforyouth.org/?s=grants" target="_blank" rel="noopener">CLICK HERE</a>.</h4>
</div>
</div>
</div>
</div>
</section>
</div>
<p>The post <a rel="nofollow" href="https://opportunitiesforyouth.org/2026/08/09/amex-shop-small-grants/">3 U.S. Federal SBIR/STTR Funding Opportunities 2026: NIH, NSF and Defense Grants for Small Businesses</a> appeared first on <a rel="nofollow" href="https://opportunitiesforyouth.org">Opportunities for Youth</a>.</p>